Income statement
USD
Annual
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Revenue | 3M | 4M | 4M | 3M | 0 |
| Gross Profit | 2M | 3M | 3M | 2M | 0 |
| Operating Income | 156K | 171K | 915K | 1M | 65K |
| EBITDA | -111K | -137K | -889K | -393K | -50K |
| Net Income | -71K | -224K | -905K | -2M | -80K |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.0002
+0.00% today
1Y Change
+100.00%
Window
Jun 23, 2025 → Jun 8, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 8, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
SheerVision, Inc. (SVSO) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 100.0% across the available one-year price window (Jun 23, 2025 → Jun 8, 2026). Baseline metrics include revenue growth of -20.8%, EPS growth of +68.2%, a dividend yield of 0.0%. What stands out right now is revenue -20.8%, EPS +68.2%, free cash flow +93.7% with operating margin 4.5% and ROIC -30.0%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SVSO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SVSO
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SVSO Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SVSO and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$79.7K
+96.6% YoY
Free Cash Flow
-$14.7K
+99.3% YoY
Revenue Growth
-20.8%
EPS Growth
+68.2%
Gross Margin
62.2%
Net Margin
-2.0%
Income statement
USD
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Revenue | 3M | 4M | 4M | 3M | 0 |
| Gross Profit | 2M | 3M | 3M | 2M | 0 |
| Operating Income | 156K | 171K | 915K | 1M | 65K |
| EBITDA | -111K | -137K | -889K | -393K | -50K |
| Net Income | -71K | -224K | -905K | -2M | -80K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18K | 112K | 265K | 1M | 6K |
| Total Assets | 838K | 961K | 856K | 2M | 7K |
| Total Liabilities | 1M | 1M | 750K | 363K | 35K |
| Shareholder Equity | -594K | -262K | 106K | 1M | -28K |
| Total Debt | 75K | 156K | 0 | 0 | 0 |
| Net Debt | 57K | 44K | -265K | -1M | -6K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
15K
+99.2% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
15K
+99.3% YoY
Key ratios
Gross Margin
62.2%
Operating Margin
4.5%
Net Margin
-2.0%
ROE
16.7%
Debt / Equity
-0.13x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.